Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease

Image: Eisai, UCL’s E2814 will enter into Alzheimer’s clinical trials in 2019. Photo: courtesy of ponsulak/Freedigitalphotos.net.